Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
33%
OVERLAP
BY WEIGHT
BY WEIGHT
6
# OF OVERLAPPING HOLDINGS
IHE
36
HOLDINGS
17%
ALSO IN MEDX
MEDX
28
HOLDINGS
21%
ALSO IN IHE
SECTOR DRIFT (IHE minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 22.1% | 16.4% | 16.4% |
|
JOHNSON & JOHNSON | 22.7% | 4.8% | 4.8% |
|
BRISTOL-MYERS SQUIBB CO | 4.3% | 5.2% | 4.3% |
|
PFIZER INC | 4.6% | 4.0% | 4.0% |
|
MERCK & CO. INC. | 4.5% | 3.4% | 3.4% |
IHE Overweight Relative to MEDX
|
JOHNSON & JOHNSON | 17.8% |
|
ELI LILLY & CO | 5.7% |
|
ROYALTY PHARMA PLC CLASS A | 4.9% |
|
VIATRIS, INC. | 4.4% |
|
ZOETIS INC | 4.3% |
|
ELANCO ANIMAL HEALTH, INC. | 3.6% |
|
CORCEPT THERAPEUTICS INC | 3.5% |
 |
JAZZ PHARMACEUTICALS PLC | 3.3% |
|
AXSOME THERAPEUTICS, INC. | 2.2% |
|
PRESTIGE BRANDS HOLDINGS INC | 2.0% |
IHE Underweight Relative to MEDX
|
ABBVIE INC | -8.8% |
 |
NOVARTIS AG-ADR | -7.3% |
|
AMGEN INC | -5.9% |
|
ALNYLAM PHARMACEUTICALS INC | -5.9% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.5% |
|
ALKERMES PLC | -4.2% |
|
CRISPR THERAPEUTICS AG | -3.2% |
|
IONIS PHARMACEUTICALS, INC. | -3.1% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.7% |
|
BIOGEN IDEC INC | -2.5% |